Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02132507 · ClinicalTrials.gov registry record
Multimodal Functional Neuroimaging in Epilepsy Patients
A clinical trial, sponsored by University of Minnesota.
- Completed
- Registry status
- 27
- Enrollment target
NCT02132507: Completed study, sponsored by University of Minnesota.
NCT02132507 is a clinical trial that has completed, run by University of Minnesota. The registered enrollment target is 27 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02132507 has completed, sponsored by University of Minnesota.
- COMPLETED
- Registry status
- 27 participants
- Enrollment target
Study Summary
The purpose of the study is to evaluate a new technology for functional neuroimaging using electroencephalography (EEG) and MRI in studying epilepsy.
Primary Outcome
Finding of epileptogenic foci in patients with focal epilepsy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 27 participants |
| Start Date | 2011-01 |
| Est. Completion | 2015-06 |
What the finished NCT02132507 record still lists
NCT02132507 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 27 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT02132507 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02132507 about?
NCT02132507 is a clinical study titled "Multimodal Functional Neuroimaging in Epilepsy Patients". The purpose of the study is to evaluate a new technology for functional neuroimaging using electroencephalography (EEG) and MRI in studying epilepsy.
What is the current status of trial NCT02132507?
This trial is currently completed. The enrollment target is 27 participants. The study started on 2011-01. Estimated completion is 2015-06.
Who is sponsoring clinical trial NCT02132507?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00912041 · 27 participants · NA
BrainGate2: Feasibility Study of an Intracortical Neural Interface System for Persons With Tetraplegia
- NCT02847559 · 27 participants · Phase 2
Optune Delivered Electric Field Therapy and Bevacizumab in Treating Patients With Recurrent or Progressive Grade 2 or 3 Meningioma
- NCT03380195 · 27 participants · NA
Effects of Watermelon Juice on Heart Rate Recovery and Post-exercise Muscle Soreness
- NCT03384238 · 27 participants · Phase 1
Panitumumab-IRDye800 in Patients With Pancreatic Cancer Undergoing Surgery
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia